BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24373735)

  • 21. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 1-(4-methanesulfonylphenyl)-5-aryl-1H-pyrazol-3-carboxylic acids: synthesis, nitric oxide release studies and anti-inflammatory activities.
    Abdellatif KR; Chowdhury MA; Dong Y; Knaus EE
    Bioorg Med Chem; 2008 Jul; 16(13):6528-34. PubMed ID: 18513975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective nitros(yl)ation induced in vivo by a nitric oxide-donating cyclooxygenase-2 inhibitor: a NObonomic analysis.
    Dhawan V; Schwalb DJ; Shumway MJ; Warren MC; Wexler RS; Zemtseva IS; Zifcak BM; Janero DR
    Free Radic Biol Med; 2005 Nov; 39(9):1191-207. PubMed ID: 16214035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of glycolamide esters of indomethacin as potential cyclooxygenase-2 (COX-2) inhibitors.
    Khanna S; Madan M; Vangoori A; Banerjee R; Thaimattam R; Jafar Sadik Basha SK; Ramesh M; Casturi SR; Pal M
    Bioorg Med Chem; 2006 Jul; 14(14):4820-33. PubMed ID: 16581252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclooxygenase-2 inhibitors. 1,5-diarylpyrrol-3-acetic esters with enhanced inhibitory activity toward cyclooxygenase-2 and improved cyclooxygenase-2/cyclooxygenase-1 selectivity.
    Biava M; Porretta GC; Poce G; Supino S; Forli S; Rovini M; Cappelli A; Manetti F; Botta M; Sautebin L; Rossi A; Pergola C; Ghelardini C; Vivoli E; Makovec F; Anzellotti P; Patrignani P; Anzini M
    J Med Chem; 2007 Nov; 50(22):5403-11. PubMed ID: 17915854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic potential for coxibs-nitric oxide releasing hybrids in cystic fibrosis.
    Consalvi S; Poce G; Ghelardini C; Di Cesare Mannelli L; Patrignani P; Bruno A; Anzini M; Calderone V; Martelli A; Testai L; Giordani A; Biava M
    Eur J Med Chem; 2021 Jan; 210():112983. PubMed ID: 33168231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, biological evaluation and docking analysis of a new series of methylsulfonyl and sulfamoyl acetamides and ethyl acetates as potent COX-2 inhibitors.
    Consalvi S; Alfonso S; Di Capua A; Poce G; Pirolli A; Sabatino M; Ragno R; Anzini M; Sartini S; La Motta C; Di Cesare Mannelli L; Ghelardini C; Biava M
    Bioorg Med Chem; 2015 Feb; 23(4):810-20. PubMed ID: 25596758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical anti-inflammatory and analgesic activities of standardized pomegranate rind extract in comparison with its marker compound ellagic acid in vivo.
    Mo J; Panichayupakaranant P; Kaewnopparat N; Nitiruangjaras A; Reanmongkol W
    J Ethnopharmacol; 2013 Jul; 148(3):901-8. PubMed ID: 23743057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Celecoxib analogs possessing a N-(4-nitrooxybutyl)piperidin-4-yl or N-(4-nitrooxybutyl)-1,2,3,6-tetrahydropyridin-4-yl nitric oxide donor moiety: synthesis, biological evaluation and nitric oxide release studies.
    Chowdhury MA; Abdellatif KR; Dong Y; Yu G; Huang Z; Rahman M; Das D; Velázquez CA; Suresh MR; Knaus EE
    Bioorg Med Chem Lett; 2010 Feb; 20(4):1324-9. PubMed ID: 20097072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acyclic triaryl olefins possessing a sulfohydroxamic acid pharmacophore: synthesis, nitric oxide/nitroxyl release, cyclooxygenase inhibition, and anti-inflammatory studies.
    Huang Z; Velázquez C; Abdellatif K; Chowdhury M; Jain S; Reisz J; Dumond J; King SB; Knaus E
    Org Biomol Chem; 2010 Sep; 8(18):4124-30. PubMed ID: 20664853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-inflammatory activity of the synthetic C-C biflavonoids.
    Park H; Kim YH; Chang HW; Kim HP
    J Pharm Pharmacol; 2006 Dec; 58(12):1661-7. PubMed ID: 17331331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and pharmacological characterization of a novel nitric oxide-releasing diclofenac derivative containing a benzofuroxan moiety.
    de Carvalho PS; Maróstica M; Gambero A; Pedrazzoli J
    Eur J Med Chem; 2010 Jun; 45(6):2489-93. PubMed ID: 20227145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inducible nitric oxide synthase and cyclooxygenase-2 participate in anti-inflammatory and analgesic effects of the natural marine compound lemnalol from Formosan soft coral Lemnalia cervicorni.
    Jean YH; Chen WF; Duh CY; Huang SY; Hsu CH; Lin CS; Sung CS; Chen IM; Wen ZH
    Eur J Pharmacol; 2008 Jan; 578(2-3):323-31. PubMed ID: 17916350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase-2.
    King JN; Dawson J; Esser RE; Fujimoto R; Kimble EF; Maniara W; Marshall PJ; O'Byrne L; Quadros E; Toutain PL; Lees P
    J Vet Pharmacol Ther; 2009 Feb; 32(1):1-17. PubMed ID: 19161451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel analgesic/anti-inflammatory agents: 1,5-diarylpyrrole nitrooxyalkyl ethers and related compounds as cyclooxygenase-2 inhibiting nitric oxide donors.
    Anzini M; Di Capua A; Valenti S; Brogi S; Rovini M; Giuliani G; Cappelli A; Vomero S; Chiasserini L; Sega A; Poce G; Giorgi G; Calderone V; Martelli A; Testai L; Sautebin L; Rossi A; Pace S; Ghelardini C; Di Cesare Mannelli L; Benetti V; Giordani A; Anzellotti P; Dovizio M; Patrignani P; Biava M
    J Med Chem; 2013 Apr; 56(8):3191-206. PubMed ID: 23534442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating the anti-inflammatory potential of Tectaria cicutaria L. rhizome extract in vitro as well as in vivo.
    Choudhari AS; Raina P; Deshpande MM; Wali AG; Zanwar A; Bodhankar SL; Kaul-Ghanekar R
    J Ethnopharmacol; 2013 Oct; 150(1):215-22. PubMed ID: 23993910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitric oxide (NO)-releasing aspirin exhibits a potent esophagoprotection in experimental model of acute reflux esophagitis. Role of nitric oxide and proinflammatory cytokines.
    Pawlik M; Pajdo R; Kwiecien S; Ptak-Belowska A; Sliwowski Z; Mazurkiewicz-Janik M; Konturek SJ; Pawlik WW; Brzozowski T
    J Physiol Pharmacol; 2011 Feb; 62(1):75-86. PubMed ID: 21451212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and pharmacological screening of novel nitric oxide donors containing 1,5-diarylpyrazolin-3-one as nontoxic NSAIDs.
    Bhandari SV; Dangre SC; Bothara KG; Patil AA; Sarkate AP; Lokwani DK; Gore ST; Deshmane BJ; Raparti VT; Khachane CV
    Eur J Med Chem; 2009 Nov; 44(11):4622-36. PubMed ID: 19647903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inducible nitric oxide synthase and cyclooxygenase-2 participate in anti-inflammatory activity of imperatorin from Glehnia littoralis.
    Huang GJ; Deng JS; Liao JC; Hou WC; Wang SY; Sung PJ; Kuo YH
    J Agric Food Chem; 2012 Feb; 60(7):1673-81. PubMed ID: 22188242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspirin analogues as dual cyclooxygenase-2/5-lipoxygenase inhibitors: synthesis, nitric oxide release, molecular modeling, and biological evaluation as anti-inflammatory agents.
    Kaur J; Bhardwaj A; Huang Z; Knaus EE
    ChemMedChem; 2012 Jan; 7(1):144-50. PubMed ID: 22095955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastrointestinal safety of novel nonsteroidal antiinflammatory drugs: selective COX-2 inhibitors and beyond.
    Coruzzi G; Venturi N; Spaggiari S
    Acta Biomed; 2007 Aug; 78(2):96-110. PubMed ID: 17933277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.